Trend of In Vitro Diagnostics (IVD) Asia-Pacific Market Technology and Market Overview

1
In Vitro Diagnostics (IVD) Asia-Pacific Market by
Manufacturers, Regions, Type and Application,
Forecast to 2021
Published on 01 March, 2016 Number of pages
180 Single User Price 2850
In Vitro Diagnostics (IVD) Asia-Pacific Market
by Manufacturers, Regions, Type and Application,
Forecast to 2021
Click Here To Check Complete Report
2
In vitro diagnostics (IVD) are diagnostic tests
practiced in an artificial environment. The
overall revenue of the Asia-Pacific IVD market
accounted for about 10.7 billion in 2014, and is
estimated to reach 15.3 billion by 2020,
registering a CAGR of 6.5 over the forecast
period. Considerable increase in the number of
chronic and infectious diseases, growing
awareness towards healthcare solutions and
technological advancements in healthcare industry
largely supplement the growth of this market.
However, stringent regulatory policies and
reimbursements issues in few countries limit the
growth of this market. The rising demand for
technologically advanced diagnostic devices, rise
in GDP and per capita income and rise in
disposable incomes facilitate a huge potential
for the IVD market in the Asia-Pacific region.The
Asia-Pacific IVD market is segmented based on
technique, product type, usability, application,
end user and country. Based on technique, the
market is segmented into immunoassays, clinical
chemistry, point-of-care, molecular diagnostics,
hematology, coagulation, microbiology and other
clinical techniques. Point-of-care is the highest
revenue-generating segment in the overall IVD
techniques market.
Avail more information from Sample Brochure of
report
3
However, the molecular diagnostics is the fastest
growing technique in the overall IVD techniques
market due to its ability to accurately detect
the primary cause of the disease.Based on product
type, the market is segmented into instruments,
reagents, data management systems and services.
Instruments segment holds the highest market
share in the Asia-Pacific IVD market followed by
rapidly growing reagents segment. Reagents are
largely used in various equipment and play a key
role in the overall diagnosis process. The
usability segment is classified as disposable and
reusable IVD devices. Doctors and clinicians
largely prefer disposable devices to avoid
infections generating larger revenue in
comparison to reusable devices.
4
The application segment is categorized into
infectious diseases diabetes, cancer/oncology,
cardiology, autoimmune diseases, nephrology, drug
testing, HIV/AIDS and others. Infectious diseases
was the highest revenue-generating segment in
2014 and would continue to maintain its position
throughout 2020, due to the rise in incidences of
infectious diseases.Hospitals and laboratories,
academics, point-of-care testing and others form
the end users segment in the Asia-Pacific IVD
market. Hospitals and laboratories generate the
highest revenue, followed by point-of-care. A
significant rise in the number of hospitals and
laboratories across the Asia-Pacific region along
with increased awareness about developments in
healthcare largely contribute to the growth of
this segment. Based on country, the Asia-Pacific
IVD market is segmented into India, China, Japan,
Australia, South Korea and rest of the
Asia-Pacific. Currently, China leads the
Asia-Pacific IVD market, owing to the high demand
for testing in outpatient clinics, huge
population base and rising medical insurance
services by the Chinese government. However,
Australia and South Korea hold the significant
market share due to the well-supported
reimbursement facilities and well-regulated IVD
devices, which comes under the regulation of
medical devices.Key companies profiled in this
market include Danaher Corporation, Roche
Diagnostics, Abbott Laboratories, Siemens
Healthcare, Alere Inc., Affymetrix Inc., Becton,
Dickinson and Company, Bio-Rad Laboratories,
BioMerieux, Vela Diagnostics and others. Product
launch and technological advancements are the few
strategies adopted by the key players of IVD
market. The companies are currently focusing on
innovative technologies such as automated and
point-of-care IVD devices.KEY BENEFITSExtensive
coverage of the Asia-Pacific IVD market including
drivers, restraints and
5
opportunities would help professionals to better
understand the market behaviourThe projections in
the report are made by analyzing the current
market trends and market potential for the period
of 20142020A comprehensive analysis of the market
scenario in terms of technologies, applications,
usability, product type end users and geography
helps identify the growth opportunities in the
Asia-Pacific IVD marketThe market attractiveness
analysis for the Asia-Pacific IVD market provides
strategic assistance to the decision makersKey
market players within the
6
Asia-Pacific IVD market are profiled in the
report and their strategies are analysed
thoroughly, which helps in understanding
competitive outlook of this marketIN VITRO
DIAGNOSTICS MARKET KEY SEGMENTSAsia-Pacific IVD
market is segmented into applications,
technology, product type, usability, end user,
and geography.By TechniquesImmunoassaysClinical
ChemistryPoint Of CareMicrobiologyMolecular
DiagnosticsWhole Blood GlucoseHematologyCoagulatio
nOther clinical techniquesBy Product
TypeInstrumentsReagentsData management
systemsServicesBy UsabilityDisposable
DevicesReusable DevicesBy ApplicationsInfectious
DiseasesDiabetesCancer/OncologyCardiologyAutoimmun
e DiseasesNephrologyDrug TestingHIV/AIDSOthersBy
End-UserHospitals and LaboratoriesAcademicsPoint
of Care TestingOthersBy CountriesChinaIndiaJapanAu
straliaSouth KoreaOthers
Make an Inquiry Before Buying
7
In Vitro Diagnostics (IVD) Asia-Pacific Market by
Manufacturers, Regions, Type and Application,
Forecast to 2021
A detailed qualitative analysis of the factors
responsible for driving and restraining growth of
In Vitro Diagnostics (IVD) Asia-Pacific Market by
Manufacturers, Regions, Type and Application,
Forecast to 2021 and future opportunities are
provided in the report.
Contact 1-302-261-5343 sales_at_marketintelreports.c
om www.marketintelreports.com
Click here to order a copy of In Vitro
Diagnostics (IVD) Asia-Pacific Market Report